Mifepristone treatment of chronic central serous chorioretinopathy

被引：21

作者：

Nielsen, Jared S.

Weinreb, Robert N.

Yannuzzi, Lawrence

Jampol, Lee M.

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA

[2] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA

[3] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA

[4] Manhattan Eye Ear & Throat Hosp, LuEsther T Mertz Retinal Res Ctr, New York, NY 10021 USA

来源：

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2007年 / 27卷 / 01期

关键词：

D O I：

10.1097/IAE.0b013e3180316fd8

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication. Copyright © by Ophthalmic Communications Society, Inc.

引用

页码：119 / 122

页数：4

共 5 条

[1]

Cadepond F, 1997, ANNU REV MED, V48, P129

[2] Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486) [J].